Recombinant adenovirus-mediated expression of tyrosine hydroxylase in 293 cells and activity assay of the expressed protein in vitro by capillary electrophoresis.
- Author:
Wen-ju WANG
1
;
Mao-sheng SUN
;
Min YAN
;
Tian-hong XIE
;
Guang-ming ZHANG
;
Hong-jun LI
Author Information
- Publication Type:Journal Article
- MeSH: Adenoviridae; genetics; metabolism; Cell Line; Electrophoresis, Capillary; Escherichia coli; genetics; metabolism; Genetic Therapy; Genetic Vectors; genetics; Humans; Levodopa; analysis; biosynthesis; genetics; Parkinson Disease; therapy; Recombinant Proteins; biosynthesis; genetics; Reverse Transcriptase Polymerase Chain Reaction; Transfection; Tyrosine 3-Monooxygenase; biosynthesis; genetics
- From: Journal of Southern Medical University 2010;30(4):681-685
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo construct a recombinant adenovirus for carry tyrosine hydroxylase (TH) gene and expressing bioactive TH protein in the animal model of Parkinson disease.
METHODSThe TH gene was inserted into the shuttle plasmid, which was transformed into E.coli BJ-5183 for homologous recombination with the adenovirus genome. 293 cells were transfected with the recombinant adenovirus genome to obtain the recombinant virus, and the transcription and expression of TH were determined by RT-PCR and immunofluorescence assay, respectively. The production of L-DOPA in the in vitro reaction system was determined using capillary electrophoresis.
RESULTSWe have successfully constructed the recombinant adenovirus. The TH mRNA and the corresponding protein were detected by RT-PCR and immunofluoresence assay in 293 cells. L-DOPA was also detected in the reaction system.
CONCLUSIONThe adenovirus constructed allows efficient expression of bioactive TH protein in vitro, which provides a basis for future study of gene therapy of Parkinson disease in animal models.